SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001600132-19-000032
Filing Date
2019-01-23
Accepted
2019-01-23 17:14:50
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 finalprossupjanuary2019cmpo.htm 424B5 565850
2 blphlogoa48.jpg GRAPHIC 32979
3 indicationtablea13.jpg GRAPHIC 54899
4 inopulseproducta22.jpg GRAPHIC 27238
  Complete submission text file 0001600132-19-000032.txt   720412
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-225878 | Film No.: 19538072
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1